An European Union (EU) Post-Approval Registry of the TREO® Stent-Graft

NATerminatedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

June 22, 2017

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2020

Conditions
Aortic Aneurysm, Abdominal
Interventions
DEVICE

TREO Stent-Graft System

The TREO® Stent-Graft is designed for use in the management of patients with AAAs and is composed of self-expanding nitinol stents sutured to polyester vascular graft fabric.

Trial Locations (16)

2820

Imelda Hospital, Bonheiden

6903

Centro Vascolare Ticino, Ospedale Regionale di Lugano, Lugano

Unknown

Imeldaziekenhuis, Bonheiden

AZ Sint Blasius, Dendermonde

Bonifatius Hospital, Lingen

University Hospital Tübingen, Tübingen

Compensorio Sanitario Bolzano, Bolzano

UMC Groningen, Groningen

UMCU, Utrecht

Complexo Hospitalario Universitario de Ourense, Ourense

Civico, Ospedale Regionale, Lugano

Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge

Manchester Royal Infirmary, Central Manchester University Hospitals, Manchester

John Radcliffe Hospital, Oxford University Hospitals, Oxford

D-48145

University Clinic and St. Franziskus Hospital Muenster, Münster

08036

Hospital Clinic Barcelona, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Bolton Medical Espana SLU

UNKNOWN

lead

Bolton Medical

INDUSTRY

NCT03187522 - An European Union (EU) Post-Approval Registry of the TREO® Stent-Graft | Biotech Hunter | Biotech Hunter